Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124218013 | 12421801 | 3 | F | 20130319 | 20160922 | 20160531 | 20160927 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-33815BI | BOEHRINGER INGELHEIM | 71.32 | YR | F | Y | 74.39000 | KG | 20160927 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124218013 | 12421801 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 300 MG | 22512 | 150 | MG | CAPSULE | BID | ||||||
| 124218013 | 12421801 | 2 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 10 MG | 0 | 10 | MG | TABLET | QD | ||||||
| 124218013 | 12421801 | 3 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 25 MCG | 0 | 25 | UG | TABLET | QD | ||||||
| 124218013 | 12421801 | 4 | C | VITAMIN C | ASCORBIC ACID | 1 | Oral | 500 MG | 0 | 500 | MG | CAPSULE | QD | ||||||
| 124218013 | 12421801 | 5 | C | CALCIUM | CALCIUM | 1 | Oral | 1000 MG | 0 | 500 | MG | TABLET | BID | ||||||
| 124218013 | 12421801 | 6 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | STRENGTH: 50000 UNIT | 0 | CAPSULE | /month | ||||||||
| 124218013 | 12421801 | 7 | C | VITAMIN B 2 | 2 | Oral | 100 MG | 0 | 100 | MG | TABLET | QD | |||||||
| 124218013 | 12421801 | 8 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | Oral | 400 MG | 0 | 400 | MG | CAPSULE | QD | ||||||
| 124218013 | 12421801 | 9 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Sublingual | INJECT ONCE A MONTH AS DIRECTED | 0 | /month | |||||||||
| 124218013 | 12421801 | 10 | C | COQ10 | UBIDECARENONE | 1 | Unknown | 1 ANZ | 0 | TABLET | QD | ||||||||
| 124218013 | 12421801 | 11 | C | FISH OIL | FISH OIL | 1 | Unknown | 1 ANZ | 0 | TABLET | QD | ||||||||
| 124218013 | 12421801 | 12 | C | SOTALOL HCL | SOTALOL | 1 | Oral | 160 MG | 0 | 80 | MG | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124218013 | 12421801 | 1 | Atrial fibrillation |
| 124218013 | 12421801 | 2 | Product used for unknown indication |
| 124218013 | 12421801 | 3 | Product used for unknown indication |
| 124218013 | 12421801 | 4 | Product used for unknown indication |
| 124218013 | 12421801 | 5 | Product used for unknown indication |
| 124218013 | 12421801 | 6 | Product used for unknown indication |
| 124218013 | 12421801 | 7 | Product used for unknown indication |
| 124218013 | 12421801 | 8 | Product used for unknown indication |
| 124218013 | 12421801 | 9 | Product used for unknown indication |
| 124218013 | 12421801 | 10 | Product used for unknown indication |
| 124218013 | 12421801 | 11 | Product used for unknown indication |
| 124218013 | 12421801 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124218013 | 12421801 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124218013 | 12421801 | Anaemia | |
| 124218013 | 12421801 | Retroperitoneal haematoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124218013 | 12421801 | 1 | 20110509 | 0 |